Insulin Resistance Intervention After Stroke Trial
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Walter N. Kernan, M.D.
Yale University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
183 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Flinders Medical Centre
Bedford Park, New South Wales, Australia
- Royal Prince Alfred
Camperstown, New South Wales, Australia
- John Hunter Hospital (university of Newcastle)
New Lambton Heights, New South Wales, Australia
- Box Hill Hospital (eastern Health)
Box Hill, Victoria, Australia
- Western Hospital (university of Melbourne)
Footscray, Victoria, Australia
- Austin Health (national Stroke Research Institute)
Heidelberg Heights, Victoria, Australia
- Royal Melbourne Hospital
Parkville, Victoria, Australia
- Royal Perth
Perth, Western Australia, Australia
- University of Alberta
Edmonton, Alberta, Canada
- Center for Neurologic Research
Lethbridge, Alberta, Canada
- Vancouver Island Health Research Centre
Victoria, British Columbia, Canada
- Robarts Research Institute
London, Ontario, Canada
- Ottawa Hospital-General Campus
Ottawa, Ontario, Canada
- Intermountain Research Consultants
Thunder Bay, Ontario, Canada
- St. Michael'S Hospital
Toronto, Ontario, Canada
- Hôpital Charles Lemoyne
Greenfield Park, Quebec, Canada
- Mcgill-Jewish General
Montreal, Quebec, Canada
- Mcgill-Montreal General
Montreal, Quebec, Canada
- Centre Hospitalier Affilie Universitaire de Quebec
Québec, Quebec, Canada
- Chum-Centre de Recherche, Hôpital Notre-Dame
Montreal, Canada
- Klinikum Altenburger Land
Altenburg, Germany
- Neurologische Klinik
Bad Neustadt an der Saale, Germany
- University Hospital-Dresden
Dresden, Germany
- University Duesseldorf/heinrich-Heine University
Düsseldorf, Germany
- University of Erlangen
Erlangen, Germany
- Alfried Krupp Hospital
Essen, Germany
- University Hospital Frankfurt
Frankfurt, Germany
- Freiburg University
Freiburg im Breisgau, Germany
- Ernst-Moritz-Arndt-University Greifswald
Greifswald, Germany
- Martin-Luther-Universitaet Halle-Wittenberg
Halle, Germany
- University Medical Center Hamburg-Eppendorf
Hamburg, Germany
- University Heidelberg
Heidelberg, Germany
- Friedrich Schiller-University Jena
Jena, Germany
- University Hospital Mainz
Mainz, Germany
- Klinikum Der Universitat Muenchen
Munich, Germany
- University Hospital Muenster
Münster, Germany
- University of Ulm
Ulm, Germany
- Soroka Medical Center
Beersheba, Israel
- B'Nai Zion Medical Center
Haifa, Israel
- Bnai-Zion Medical Center
Haifa, Israel
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2005
- Primary completion
- 30 Nov 2015
- Completion
- 30 Nov 2015
- Last update posted
- 27 Apr 2020
- Registered enrollment
- 3,876
- Registry id
- NCT00091949
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.